Acute Myeloid Leukemia

Oct 5, 2024, 11:39 | Insight

Talha Badar: Transplant or no transplant for TP53 mutated AML

Talha Badar shared a post on X about a recent paper titled "Transplant or no…

Oct 1, 2024, 17:45 | Insight

Talha Badar: Different aspects of TP53 mutated AML

Talha Badar shared a post on X: "I will share our collaborative effort in looking at…

Sep 28, 2024, 16:29 | Blog

Thor Halfdanarson: A good review for those encountering patients with t-MN

Thor Halfdanarson, Vice President at North American Neuroendocrine Tumor Society, shared the following insights about a…

Sep 10, 2024, 00:28 | Blog

Chloe’s leukemia battle: ‘My knees just gave way’ - Children’s Cancer Institute

Children’s Cancer Institute shared the following on LinkedIn: “Chloe was a happy 9-year-old who loved…

Aug 29, 2024, 20:11 | Career

Alique Topalian received the Inspirational Award from the Armenian Bone Marrow Donor Registry

Alique Topalian shared a post by University of Cincinnati Cancer Center, on LinkedIn adding: “So…

Aug 28, 2024, 15:53 | Career

Alique Topalian: I received the Inspirational Award from the Armenian Bone Marrow Donor Registry

Alique Topalian shared on LinkedIn: "This weekend I received one of the greatest honors of…

Aug 24, 2024, 10:51 | Insight

Shahrin Ahmed: High health care utilization and poor survival rate in older adults with AML

Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: “Older…

Aug 17, 2024, 07:45 | Insight

Razan Mohty: Outcomes of patients with IDH1 or 2 mutated AML after alloHCT

Razan Mohty, Assistant Professor at UAB Medicine, shared a post on X about a recent…

Aug 10, 2024, 01:18 | Blog

JAMA Oncology Review: The Latest Treatment Options for Acute Myeloid Leukemia by Sylvester Comprehensive Cancer Center

Recently approved drugs are rapidly changing the treatment of patients with acute myeloid leukemia (AML),…

Aug 9, 2024, 09:44 | Blog

Talha Badar: AML, MDS, and CML highlights from EHA24

Talha Badar posted on LinkedIn: "Acute myeloid leukemia AML MDS highlights from recently conducted European Hematology…

Aug 4, 2024, 07:01 | Insight

Rama Al Hamed: Allogeneic SCT in de novo core-binding factor AML in first complete remission

Rama Al Hamed, Hematology/Oncology Fellow at Herbert Irving Comprehensive Cancer Centre, shared on X: "Allogeneic…

Aug 4, 2024, 06:30 | Insight

Lisa Bouchier-Hayes: Caspase-2 in nucleophosmin-mutated acute myeloid leukemia

Lisa Bouchier-Hayes, Associate Professor at Baylor College of Medicine, shared on X: "So excited to…

Aug 1, 2024, 02:29 | Blog

Early Intervention Key to Managing Shwachman-Diamond Syndrome: Insights from Dana-Farber's Molecular Tumor Board

Dana-Farber Cancer Institute shared a post on LinkedIn: "Imagine trying to navigate a paper map…

Jul 21, 2024, 17:12 | Insight

2024 Visionaries of the Year National Winners - The Leukemia and Lymphoma Society

The Leukemia and Lymphoma Society shared a post on LinkedIn: "Meet the incredible 2024 Visionaries…

Jul 19, 2024, 13:27 | Insight

Fadi Haddad: Hyperleukocytosis in Acute myeloid leukemia

Fadi Haddad, Assistant Professor at Leukemia Department at MD Anderson Cancer Center, shared a post…

Jul 19, 2024, 13:19 | Insight

Sanam Loghavi: Optical genome mapping in acute myeloid leukemia

Sanam Loghavi, shared a post on X about a recent paper titled "Optical genome mapping improves…

Jul 15, 2024, 13:21 | Blog

Talha Badar: CRh as a Palliative Endpoint for Treatment of Acute Myeloid Leukemia

Talha Badar shared on X: "Complete remission with partial hematological recovery as a palliative endpoint for…

Jul 11, 2024, 02:39 | Blog

Mathijs Sanders: Grateful for receiving the LSBR Fellowship!

Mathijs Sanders, Researcher, Erasmus MC Cancer Institute, shared on X: "Extremely grateful for receiving the LSBR…

Jul 7, 2024, 16:11 | Insight

Amer Zeidan: Excellent paper by Abdulrahman Alhajahjeh under mentorship of Maximilian Stahl

Amer Zeidan shared a post on X: "Another excellent paper by University of Jordan super…

Jul 4, 2024, 10:46 | Positive

Dr. Eytan Stein to lead a novel clinical trial for AML patients

Memorial Sloan Kettering Cancer Center shared on X: "A new class of drugs known as…

Jun 29, 2024, 16:57 | Insight

MD Anderson Research Highlights: EHA 2024 Special Edition

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…

Jun 19, 2024, 23:22 | Blog

Amer Zeidan: Looking forward to finding cures for all AML and MDS patients

Amer Zeidan shared on X: "Looking forward to finding cures for all Acute Myeloid Leukemia…

Jun 18, 2024, 23:17 | Insight

Talha Badar: TP53 mutation in Myeloproliferative neoplasms

Talha Badar shared on X: , "Genomic landscape, impact allelic burden, time to…

Jun 18, 2024, 14:51 | Insight

Amer Zeidan: Our newest paper on 61 TP53-mutated AML

Amer Zeidan shared on X: "Our newest paper with a detailed Integrated analysis of genetic,…

Jun 13, 2024, 09:00 | Insight

Key Advances in Targeted Radiotherapies at SNMMI24 by Actinium

Actinium Pharmaceuticals presented compelling data from their diverse clinical trials at SNMMI24: Key among these…

Jun 2, 2024, 22:16 | Insight

ASCO: Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia

Clinical trial results suggest new treatment options could reduce need for stem cell transplants and…

May 30, 2024, 09:41 | Blog

Sarita Jaiswal: What could be a greater gift than what we got today on Cancer Day from a little girl

Sarita Jaiswal, Program Director and consultant at Dharamshila Narayana superspecility hospital, shared on their LinkedIn:…

May 30, 2024, 02:01 | Blog

Wei Zhang: P21 and cancer

Wei Zhang, Director of Center for Cancer Genomics and Precision Oncology at Wake Forest Baptist…

May 24, 2024, 10:50 | Cancer Types

Acute Myeloid Leukemia: What patients should know about

What is Acute Myeloid Leukemia? Acute myeloid leukemia (AML) is a severe and aggressive form…

May 13, 2024, 13:11 | Insight

Justin Kaner: To transplant or not to transplant…..

Justin Kaner, Assistant Professor of the Leukemia Program at Weill Cornell, shared on X: "To…

May 12, 2024, 07:00 | Blog

Ellen Madarang: We proved that treatment of 80-90 year olds with AML can be done

Ellen Madarang, Hematology Oncology Clinical Pharmacist at Sylvester Comprehensive Cancer Center, shared the following post…

May 12, 2024, 06:02 | Insight

Rasoul Pourebrahim: Our latest publication on studying mutant p53-driven Acute Myeloid Leukemia

Rasoul Pourebrahim, Assistant Professor at MD Anderson, made the following post on LinkedIn: "Our paper…

May 12, 2024, 01:40 | Insight

Justin Watts: A significant portion of patients at the extremes of older age (80-90) still derive benefit from the VEN-HMA regimen

Justin Watts et al. report that standard of care treatment for acute myeloid leukemia extends…

May 1, 2024, 21:39 | Blog

It’s the one-two punch cancer treatment that ‘floats like a butterfly, and STINGs like a bee’! - WEHI (Walter and Eliza Hall Institute of Medical Research)

WEHI (Walter and Eliza Hall Institute of Medical Research) made the foll0wing post on LinkedIn:…

Apr 27, 2024, 14:29 | Opinion

Amer Zeidan: I find MRD literature increasingly confusing as it pertains to decision making

Amer Zeidan shared a post on X: "I have to say I find MRD literature…

Apr 26, 2024, 18:12 | Insight

Invariant natural killer T cells response to acute myeloid leukemia and pancreatic cancer liver metastasis - Easy IMMUNO-ATMPs

Easy IMMUNO-ATMPs shared on LinkedIn: “Invariant natural killer T cells response to acute myeloid leukemia…

Apr 21, 2024, 06:16 | Dialogues

Oncodaily Dialogues #8 Mikkael Sekeres/ Hosted by Roupen Odabashian

In our ongoing series called “OncoDaily Dialogues”, we consistently feature prominent individuals in the field of…

Apr 12, 2024, 11:59 | Insight

Wei Zhang: Congratulations to an outstanding physician scientist Tim Pardee for the new R21 grant that addresses health disparities in acute myeloid leukemia

Wei Zhang, Director at Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer…

Mar 23, 2024, 04:57 | Insight

Alicia Perzolli: Happy to share my first publication for my Ph.D. at Princess Máxima Center for Pediatric Oncology about 'Targeting the innate immune system in pediatric and adult AML'

Mar 11, 2024, 03:24 | Career

Amer Zeidan was appointed as the inaugural Chief of the Division of Hematologic Malignancies at Yale Cancer Center

Yale Cancer Center shared on LinkedIn: "We are pleased to announce that Amer Zeidan was…

Mar 10, 2024, 20:49 | Insight

Hagop Kantarjian: In this phase 2 study, a convenient, fully-oral regimen was effective and safe in an older/unfit population with acute myeloid leukemia

Hagop Kantarjian, a Professor and Chair of the Department of Leukemia at The University…

Dec 7, 2023, 04:32 | Insight

Yuki Nishida: This is one of the continuous efforts to overcome therapy resistance in acute myeloid leukemia by enhancing the activity of p53

Yuki Nishida, Instructor at MD Anderson Cancer Center, recently shared on LinkedIn: "Our paper has…

Oct 7, 2023, 19:19 | Insight

Johanna Olweus: Excited to share our work, which shows that T cells targeting a shared neoantigen eliminate acute myeloid leukemia, including cancer stem cells, in vivo, in a disease-relevant model.

Oct 1, 2023, 04:00 | Blog

Maite Gorostegui: The one most adaptable to change is the one that survives...

Quoting Maite Gorostegui, Pediatric Oncologist at the Pediatric Cancer Center Barcelona, on LinkedIn: “The One…

All: 44 Posts: 1 - 100